新型冠状病毒肺炎与垂体卒中:单中心病例系列及文献回顾
患者主要表现为头痛和视力改变,经手术减压及内分泌治疗均获改善。COVID-19感染可能是垂体卒中的危险因素,但需进一步研究。
要点
- 垂体卒中合并COVID-19感染患者常表现为头痛和视力改变。
- 手术减压联合内分泌治疗可改善视觉症状。
- COVID-19感染可能是垂体卒中的潜在危险因素。
核心结论
- COVID-19感染可能是垂体卒中的危险因素,但研究受限无法确定因果关系。
主要发现
- 识别出3例连续PA合并COVID-19感染病例,常见症状为头痛和视力改变。
- 患者经手术减压和内分泌药物治疗后视觉症状改善。
- 所有患者围手术期COVID-19感染经PCR检测证实。
- 结合文献共确认10例COVID-19感染背景下的PA病例。
临床怎么用
- 对COVID-19感染患者出现头痛和视力改变时应警惕垂体卒中可能。
- 确诊后可采用手术减压及内分泌管理改善视觉症状。
局限性
- 本研究为单中心回顾性病例系列,样本量小,无法得出两疾病关系的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pituitary apoplexy (PA) is a rare, but life-threatening, condition characterized by pituitary infarction and hemorrhage, most often in the setting of a preexisting adenoma. The risk factors and mechanisms associated with PA are poorly understood. Although neurovascular manifestations of coronavirus disease 2019 (COVID-19) infection have been documented, its association with PA has not yet been determined. METHODS: From a prospectively collected database of patients treated at a tertiary care center for pituitary adenoma, we conducted a retrospective medical record review of PA cases during the COVID-19 pandemic from March 2020 to December 2020. We also conducted a literature review to identify other reported cases. RESULTS: We identified 3 consecutive cases of PA and concomitant COVID-19 infection. The most common symptoms at presentation were headache and vision changes. The included patients were successfully treated with surgical decompression and medical management of the associated endocrinopathy, ultimately experiencing improvement in their visual symptoms at the latest follow-up examination. COVID-19 infection in the perioperative period was corroborated by polymerase chain reaction test results in all the patients. CONCLUSIONS: With the addition of our series to the literature, 10 cases of PA in the setting of COVID-19 infection have been confirmed. The present series was limited in its ability to draw conclusions about the relationship between these 2 entities. However, COVID-19 infection might represent a risk factor for the development of PA. Further studies are required.
引用
- Martinez-Perez R, Kortz MW, Carroll BW, et al. Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature. World Neurosurg. 2021. PMID: 34129968. doi:10.1016/j.wneu.2021.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。